Global Inavolisib Tablets Supply, Demand and Key Producers, 2026-2032
The global Inavolisib Tablets market size is expected to reach $ 940 million by 2032, rising at a market growth of 22.5% CAGR during the forecast period (2026-2032).
Inavolisib is an orally administered small-molecule selective inhibitor of PI3K? (phosphatidylinositol 3-kinase alpha isoform). It is primarily used for the treatment of patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2?) advanced or metastatic breast cancer. The drug exerts its anti-tumor effects by selectively inhibiting the PI3K/AKT/mTOR signaling pathway, thereby blocking tumor cell proliferation and survival signals.
Inavolisib is typically used in combination with endocrine therapy and CDK4/6 inhibitors. It has significant clinical value in delaying disease progression and improving patient outcomes, and represents a new generation of advances in PI3K-targeted therapy.In 2025, global Inavolisib production reached approximately 30,000 bottles.
Inavolisib, as a new-generation PI3K?-selective inhibitor, holds significant development potential in the treatment market for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2?) advanced or metastatic breast cancer with PIK3CA mutations. With the continuous rise in global breast cancer incidence and the increasing penetration of precision molecular diagnostics—particularly PIK3CA testing—the PI3K pathway-targeted therapy market is gradually expanding.
Compared with first-generation PI3K inhibitors, Inavolisib demonstrates improved selectivity, safety, and potential in combination therapy with CDK4/6 inhibitors, which may enhance its clinical utilization. From a competitive landscape perspective, the field already includes established products such as alpelisib. However, Inavolisib is expected to achieve differentiated competition in the future due to its superior clinical data and combination treatment strategies.
Looking ahead, with ongoing global regulatory approvals, standardization of combination therapy regimens, and expansion of reimbursement coverage, its market size is expected to grow rapidly, securing an important position in the HR+/HER2? breast cancer precision therapy landscape.
This report studies the global Inavolisib Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inavolisib Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inavolisib Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inavolisib Tablets total production and demand, 2021-2032, (Units)
Global Inavolisib Tablets total production value, 2021-2032, (USD Million)
Global Inavolisib Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Inavolisib Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Inavolisib Tablets domestic production, consumption, key domestic manufacturers and share
Global Inavolisib Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Inavolisib Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Inavolisib Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Inavolisib Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Genentech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inavolisib Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Inavolisib Tablets Market, By Region:
1. How big is the global Inavolisib Tablets market?
2. What is the demand of the global Inavolisib Tablets market?
3. What is the year over year growth of the global Inavolisib Tablets market?
4. What is the production and production value of the global Inavolisib Tablets market?
5. Who are the key producers in the global Inavolisib Tablets market?
6. What are the growth factors driving the market demand?
Inavolisib is an orally administered small-molecule selective inhibitor of PI3K? (phosphatidylinositol 3-kinase alpha isoform). It is primarily used for the treatment of patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2?) advanced or metastatic breast cancer. The drug exerts its anti-tumor effects by selectively inhibiting the PI3K/AKT/mTOR signaling pathway, thereby blocking tumor cell proliferation and survival signals.
Inavolisib is typically used in combination with endocrine therapy and CDK4/6 inhibitors. It has significant clinical value in delaying disease progression and improving patient outcomes, and represents a new generation of advances in PI3K-targeted therapy.In 2025, global Inavolisib production reached approximately 30,000 bottles.
Inavolisib, as a new-generation PI3K?-selective inhibitor, holds significant development potential in the treatment market for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2?) advanced or metastatic breast cancer with PIK3CA mutations. With the continuous rise in global breast cancer incidence and the increasing penetration of precision molecular diagnostics—particularly PIK3CA testing—the PI3K pathway-targeted therapy market is gradually expanding.
Compared with first-generation PI3K inhibitors, Inavolisib demonstrates improved selectivity, safety, and potential in combination therapy with CDK4/6 inhibitors, which may enhance its clinical utilization. From a competitive landscape perspective, the field already includes established products such as alpelisib. However, Inavolisib is expected to achieve differentiated competition in the future due to its superior clinical data and combination treatment strategies.
Looking ahead, with ongoing global regulatory approvals, standardization of combination therapy regimens, and expansion of reimbursement coverage, its market size is expected to grow rapidly, securing an important position in the HR+/HER2? breast cancer precision therapy landscape.
This report studies the global Inavolisib Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inavolisib Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inavolisib Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inavolisib Tablets total production and demand, 2021-2032, (Units)
Global Inavolisib Tablets total production value, 2021-2032, (USD Million)
Global Inavolisib Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Inavolisib Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Inavolisib Tablets domestic production, consumption, key domestic manufacturers and share
Global Inavolisib Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Inavolisib Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Inavolisib Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Inavolisib Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Genentech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inavolisib Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Inavolisib Tablets Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 5 mg
- 10 mg
- Hospital
- Retail
- Online
- Oral Administration
- Intravenous Administration, IV
- Tablet
- Capsule
- HR+/HER2- Advanced or Metastatic Breast Cancer
- PIK3CA-Mutated Tumor Targeted Therapy
- Combination Therapy Applications
- Others
- Roche
- Genentech
1. How big is the global Inavolisib Tablets market?
2. What is the demand of the global Inavolisib Tablets market?
3. What is the year over year growth of the global Inavolisib Tablets market?
4. What is the production and production value of the global Inavolisib Tablets market?
5. Who are the key producers in the global Inavolisib Tablets market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inavolisib Tablets Introduction
1.2 World Inavolisib Tablets Supply & Forecast
1.2.1 World Inavolisib Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Inavolisib Tablets Production (2021-2032)
1.2.3 World Inavolisib Tablets Pricing Trends (2021-2032)
1.3 World Inavolisib Tablets Production by Region (Based on Production Site)
1.3.1 World Inavolisib Tablets Production Value by Region (2021-2032)
1.3.2 World Inavolisib Tablets Production by Region (2021-2032)
1.3.3 World Inavolisib Tablets Average Price by Region (2021-2032)
1.3.4 North America Inavolisib Tablets Production (2021-2032)
1.3.5 Europe Inavolisib Tablets Production (2021-2032)
1.3.6 China Inavolisib Tablets Production (2021-2032)
1.3.7 Japan Inavolisib Tablets Production (2021-2032)
1.3.8 India Inavolisib Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inavolisib Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inavolisib Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Inavolisib Tablets Demand (2021-2032)
2.2 World Inavolisib Tablets Consumption by Region
2.2.1 World Inavolisib Tablets Consumption by Region (2021-2026)
2.2.2 World Inavolisib Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Inavolisib Tablets Consumption (2021-2032)
2.4 China Inavolisib Tablets Consumption (2021-2032)
2.5 Europe Inavolisib Tablets Consumption (2021-2032)
2.6 Japan Inavolisib Tablets Consumption (2021-2032)
2.7 South Korea Inavolisib Tablets Consumption (2021-2032)
2.8 ASEAN Inavolisib Tablets Consumption (2021-2032)
2.9 India Inavolisib Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inavolisib Tablets Production Value by Manufacturer (2021-2026)
3.2 World Inavolisib Tablets Production by Manufacturer (2021-2026)
3.3 World Inavolisib Tablets Average Price by Manufacturer (2021-2026)
3.4 Inavolisib Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inavolisib Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inavolisib Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Inavolisib Tablets in 2025
3.6 Inavolisib Tablets Market: Overall Company Footprint Analysis
3.6.1 Inavolisib Tablets Market: Region Footprint
3.6.2 Inavolisib Tablets Market: Company Product Type Footprint
3.6.3 Inavolisib Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inavolisib Tablets Production Value Comparison
4.1.1 United States VS China: Inavolisib Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Inavolisib Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Inavolisib Tablets Production Comparison
4.2.1 United States VS China: Inavolisib Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Inavolisib Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Inavolisib Tablets Consumption Comparison
4.3.1 United States VS China: Inavolisib Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Inavolisib Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Inavolisib Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Inavolisib Tablets Production (2021-2026)
4.5 China Based Inavolisib Tablets Manufacturers and Market Share
4.5.1 China Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Inavolisib Tablets Production (2021-2026)
4.6 Rest of World Based Inavolisib Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Inavolisib Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Inavolisib Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 5 mg
5.2.2 10 mg
5.3 Market Segment by Type
5.3.1 World Inavolisib Tablets Production by Type (2021-2032)
5.3.2 World Inavolisib Tablets Production Value by Type (2021-2032)
5.3.3 World Inavolisib Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Inavolisib Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channel
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channel
6.3.1 World Inavolisib Tablets Production by Sales Channel (2021-2032)
6.3.2 World Inavolisib Tablets Production Value by Sales Channel (2021-2032)
6.3.3 World Inavolisib Tablets Average Price by Sales Channel (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World Inavolisib Tablets Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Oral Administration
7.2.2 Intravenous Administration, IV
7.3 Market Segment by Route of Administration
7.3.1 World Inavolisib Tablets Production by Route of Administration (2021-2032)
7.3.2 World Inavolisib Tablets Production Value by Route of Administration (2021-2032)
7.3.3 World Inavolisib Tablets Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORMS
8.1 World Inavolisib Tablets Market Size Overview by Dosage Forms: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Forms
8.2.1 Tablet
8.2.2 Capsule
8.3 Market Segment by Dosage Forms
8.3.1 World Inavolisib Tablets Production by Dosage Forms (2021-2032)
8.3.2 World Inavolisib Tablets Production Value by Dosage Forms (2021-2032)
8.3.3 World Inavolisib Tablets Average Price by Dosage Forms (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Inavolisib Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 HR+/HER2- Advanced or Metastatic Breast Cancer
9.2.2 PIK3CA-Mutated Tumor Targeted Therapy
9.2.3 Combination Therapy Applications
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Inavolisib Tablets Production by Application (2021-2032)
9.3.2 World Inavolisib Tablets Production Value by Application (2021-2032)
9.3.3 World Inavolisib Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Inavolisib Tablets Product and Services
10.1.4 Roche Inavolisib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Genentech
10.2.1 Genentech Details
10.2.2 Genentech Major Business
10.2.3 Genentech Inavolisib Tablets Product and Services
10.2.4 Genentech Inavolisib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Genentech Recent Developments/Updates
10.2.6 Genentech Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Inavolisib Tablets Industry Chain
11.2 Inavolisib Tablets Upstream Analysis
11.2.1 Inavolisib Tablets Core Raw Materials
11.2.2 Main Manufacturers of Inavolisib Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Inavolisib Tablets Production Mode
11.6 Inavolisib Tablets Procurement Model
11.7 Inavolisib Tablets Industry Sales Model and Sales Channels
11.7.1 Inavolisib Tablets Sales Model
11.7.2 Inavolisib Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Inavolisib Tablets Introduction
1.2 World Inavolisib Tablets Supply & Forecast
1.2.1 World Inavolisib Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Inavolisib Tablets Production (2021-2032)
1.2.3 World Inavolisib Tablets Pricing Trends (2021-2032)
1.3 World Inavolisib Tablets Production by Region (Based on Production Site)
1.3.1 World Inavolisib Tablets Production Value by Region (2021-2032)
1.3.2 World Inavolisib Tablets Production by Region (2021-2032)
1.3.3 World Inavolisib Tablets Average Price by Region (2021-2032)
1.3.4 North America Inavolisib Tablets Production (2021-2032)
1.3.5 Europe Inavolisib Tablets Production (2021-2032)
1.3.6 China Inavolisib Tablets Production (2021-2032)
1.3.7 Japan Inavolisib Tablets Production (2021-2032)
1.3.8 India Inavolisib Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inavolisib Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inavolisib Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Inavolisib Tablets Demand (2021-2032)
2.2 World Inavolisib Tablets Consumption by Region
2.2.1 World Inavolisib Tablets Consumption by Region (2021-2026)
2.2.2 World Inavolisib Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Inavolisib Tablets Consumption (2021-2032)
2.4 China Inavolisib Tablets Consumption (2021-2032)
2.5 Europe Inavolisib Tablets Consumption (2021-2032)
2.6 Japan Inavolisib Tablets Consumption (2021-2032)
2.7 South Korea Inavolisib Tablets Consumption (2021-2032)
2.8 ASEAN Inavolisib Tablets Consumption (2021-2032)
2.9 India Inavolisib Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inavolisib Tablets Production Value by Manufacturer (2021-2026)
3.2 World Inavolisib Tablets Production by Manufacturer (2021-2026)
3.3 World Inavolisib Tablets Average Price by Manufacturer (2021-2026)
3.4 Inavolisib Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inavolisib Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inavolisib Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Inavolisib Tablets in 2025
3.6 Inavolisib Tablets Market: Overall Company Footprint Analysis
3.6.1 Inavolisib Tablets Market: Region Footprint
3.6.2 Inavolisib Tablets Market: Company Product Type Footprint
3.6.3 Inavolisib Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inavolisib Tablets Production Value Comparison
4.1.1 United States VS China: Inavolisib Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Inavolisib Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Inavolisib Tablets Production Comparison
4.2.1 United States VS China: Inavolisib Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Inavolisib Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Inavolisib Tablets Consumption Comparison
4.3.1 United States VS China: Inavolisib Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Inavolisib Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Inavolisib Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Inavolisib Tablets Production (2021-2026)
4.5 China Based Inavolisib Tablets Manufacturers and Market Share
4.5.1 China Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Inavolisib Tablets Production (2021-2026)
4.6 Rest of World Based Inavolisib Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Inavolisib Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inavolisib Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Inavolisib Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Inavolisib Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 5 mg
5.2.2 10 mg
5.3 Market Segment by Type
5.3.1 World Inavolisib Tablets Production by Type (2021-2032)
5.3.2 World Inavolisib Tablets Production Value by Type (2021-2032)
5.3.3 World Inavolisib Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Inavolisib Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channel
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channel
6.3.1 World Inavolisib Tablets Production by Sales Channel (2021-2032)
6.3.2 World Inavolisib Tablets Production Value by Sales Channel (2021-2032)
6.3.3 World Inavolisib Tablets Average Price by Sales Channel (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World Inavolisib Tablets Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Oral Administration
7.2.2 Intravenous Administration, IV
7.3 Market Segment by Route of Administration
7.3.1 World Inavolisib Tablets Production by Route of Administration (2021-2032)
7.3.2 World Inavolisib Tablets Production Value by Route of Administration (2021-2032)
7.3.3 World Inavolisib Tablets Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORMS
8.1 World Inavolisib Tablets Market Size Overview by Dosage Forms: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Forms
8.2.1 Tablet
8.2.2 Capsule
8.3 Market Segment by Dosage Forms
8.3.1 World Inavolisib Tablets Production by Dosage Forms (2021-2032)
8.3.2 World Inavolisib Tablets Production Value by Dosage Forms (2021-2032)
8.3.3 World Inavolisib Tablets Average Price by Dosage Forms (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Inavolisib Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 HR+/HER2- Advanced or Metastatic Breast Cancer
9.2.2 PIK3CA-Mutated Tumor Targeted Therapy
9.2.3 Combination Therapy Applications
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Inavolisib Tablets Production by Application (2021-2032)
9.3.2 World Inavolisib Tablets Production Value by Application (2021-2032)
9.3.3 World Inavolisib Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Inavolisib Tablets Product and Services
10.1.4 Roche Inavolisib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Genentech
10.2.1 Genentech Details
10.2.2 Genentech Major Business
10.2.3 Genentech Inavolisib Tablets Product and Services
10.2.4 Genentech Inavolisib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Genentech Recent Developments/Updates
10.2.6 Genentech Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Inavolisib Tablets Industry Chain
11.2 Inavolisib Tablets Upstream Analysis
11.2.1 Inavolisib Tablets Core Raw Materials
11.2.2 Main Manufacturers of Inavolisib Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Inavolisib Tablets Production Mode
11.6 Inavolisib Tablets Procurement Model
11.7 Inavolisib Tablets Industry Sales Model and Sales Channels
11.7.1 Inavolisib Tablets Sales Model
11.7.2 Inavolisib Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World InavolisibTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World InavolisibTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World InavolisibTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World InavolisibTablets Production Value Market Share by Region (2021-2026)
Table 5. World InavolisibTablets Production Value Market Share by Region (2027-2032)
Table 6. World InavolisibTablets Production by Region (2021-2026) & (Units)
Table 7. World InavolisibTablets Production by Region (2027-2032) & (Units)
Table 8. World InavolisibTablets Production Market Share by Region (2021-2026)
Table 9. World InavolisibTablets Production Market Share by Region (2027-2032)
Table 10. World InavolisibTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World InavolisibTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. InavolisibTablets Major Market Trends
Table 13. World InavolisibTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World InavolisibTablets Consumption by Region (2021-2026) & (Units)
Table 15. World InavolisibTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World InavolisibTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key InavolisibTablets Producers in 2025
Table 18. World InavolisibTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key InavolisibTablets Producers in 2025
Table 20. World InavolisibTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global InavolisibTablets Company Evaluation Quadrant
Table 22. World InavolisibTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and InavolisibTablets Production Site of Key Manufacturer
Table 24. InavolisibTablets Market: Company Product Type Footprint
Table 25. InavolisibTablets Market: Company Product Application Footprint
Table 26. InavolisibTablets Competitive Factors
Table 27. InavolisibTablets New Entrant and Capacity Expansion Plans
Table 28. InavolisibTablets Mergers & Acquisitions Activity
Table 29. United States VS China InavolisibTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China InavolisibTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China InavolisibTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based InavolisibTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers InavolisibTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 37. China Based InavolisibTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers InavolisibTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 42. Rest of World Based InavolisibTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers InavolisibTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 47. World InavolisibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World InavolisibTablets Production by Type (2021-2026) & (Units)
Table 49. World InavolisibTablets Production by Type (2027-2032) & (Units)
Table 50. World InavolisibTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World InavolisibTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World InavolisibTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World InavolisibTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World InavolisibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 55. World InavolisibTablets Production by Sales Channel (2021-2026) & (Units)
Table 56. World InavolisibTablets Production by Sales Channel (2027-2032) & (Units)
Table 57. World InavolisibTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 58. World InavolisibTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 59. World InavolisibTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 60. World InavolisibTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 61. World InavolisibTablets Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World InavolisibTablets Production by Route of Administration (2021-2026) & (Units)
Table 63. World InavolisibTablets Production by Route of Administration (2027-2032) & (Units)
Table 64. World InavolisibTablets Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World InavolisibTablets Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World InavolisibTablets Average Price by Route of Administration (2021-2026) & (US$/Unit)
Table 67. World InavolisibTablets Average Price by Route of Administration (2027-2032) & (US$/Unit)
Table 68. World InavolisibTablets Production Value by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 69. World InavolisibTablets Production by Dosage Forms (2021-2026) & (Units)
Table 70. World InavolisibTablets Production by Dosage Forms (2027-2032) & (Units)
Table 71. World InavolisibTablets Production Value by Dosage Forms (2021-2026) & (USD Million)
Table 72. World InavolisibTablets Production Value by Dosage Forms (2027-2032) & (USD Million)
Table 73. World InavolisibTablets Average Price by Dosage Forms (2021-2026) & (US$/Unit)
Table 74. World InavolisibTablets Average Price by Dosage Forms (2027-2032) & (US$/Unit)
Table 75. World InavolisibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World InavolisibTablets Production by Application (2021-2026) & (Units)
Table 77. World InavolisibTablets Production by Application (2027-2032) & (Units)
Table 78. World InavolisibTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World InavolisibTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World InavolisibTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World InavolisibTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche InavolisibTablets Product and Services
Table 85. Roche InavolisibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Genentech Basic Information, Manufacturing Base and Competitors
Table 89. Genentech Major Business
Table 90. Genentech InavolisibTablets Product and Services
Table 91. Genentech InavolisibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Genentech Recent Developments/Updates
Table 93. Genentech Competitive Strengths & Weaknesses
Table 94. Global Key Players of InavolisibTablets Upstream (Raw Materials)
Table 95. Global InavolisibTablets Typical Customers
Table 96. InavolisibTablets Typical Distributors
Table 1. World InavolisibTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World InavolisibTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World InavolisibTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World InavolisibTablets Production Value Market Share by Region (2021-2026)
Table 5. World InavolisibTablets Production Value Market Share by Region (2027-2032)
Table 6. World InavolisibTablets Production by Region (2021-2026) & (Units)
Table 7. World InavolisibTablets Production by Region (2027-2032) & (Units)
Table 8. World InavolisibTablets Production Market Share by Region (2021-2026)
Table 9. World InavolisibTablets Production Market Share by Region (2027-2032)
Table 10. World InavolisibTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World InavolisibTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. InavolisibTablets Major Market Trends
Table 13. World InavolisibTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World InavolisibTablets Consumption by Region (2021-2026) & (Units)
Table 15. World InavolisibTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World InavolisibTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key InavolisibTablets Producers in 2025
Table 18. World InavolisibTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key InavolisibTablets Producers in 2025
Table 20. World InavolisibTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global InavolisibTablets Company Evaluation Quadrant
Table 22. World InavolisibTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and InavolisibTablets Production Site of Key Manufacturer
Table 24. InavolisibTablets Market: Company Product Type Footprint
Table 25. InavolisibTablets Market: Company Product Application Footprint
Table 26. InavolisibTablets Competitive Factors
Table 27. InavolisibTablets New Entrant and Capacity Expansion Plans
Table 28. InavolisibTablets Mergers & Acquisitions Activity
Table 29. United States VS China InavolisibTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China InavolisibTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China InavolisibTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based InavolisibTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers InavolisibTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 37. China Based InavolisibTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers InavolisibTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 42. Rest of World Based InavolisibTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers InavolisibTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers InavolisibTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers InavolisibTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers InavolisibTablets Production Market Share (2021-2026)
Table 47. World InavolisibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World InavolisibTablets Production by Type (2021-2026) & (Units)
Table 49. World InavolisibTablets Production by Type (2027-2032) & (Units)
Table 50. World InavolisibTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World InavolisibTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World InavolisibTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World InavolisibTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World InavolisibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 55. World InavolisibTablets Production by Sales Channel (2021-2026) & (Units)
Table 56. World InavolisibTablets Production by Sales Channel (2027-2032) & (Units)
Table 57. World InavolisibTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 58. World InavolisibTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 59. World InavolisibTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 60. World InavolisibTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 61. World InavolisibTablets Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World InavolisibTablets Production by Route of Administration (2021-2026) & (Units)
Table 63. World InavolisibTablets Production by Route of Administration (2027-2032) & (Units)
Table 64. World InavolisibTablets Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World InavolisibTablets Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World InavolisibTablets Average Price by Route of Administration (2021-2026) & (US$/Unit)
Table 67. World InavolisibTablets Average Price by Route of Administration (2027-2032) & (US$/Unit)
Table 68. World InavolisibTablets Production Value by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 69. World InavolisibTablets Production by Dosage Forms (2021-2026) & (Units)
Table 70. World InavolisibTablets Production by Dosage Forms (2027-2032) & (Units)
Table 71. World InavolisibTablets Production Value by Dosage Forms (2021-2026) & (USD Million)
Table 72. World InavolisibTablets Production Value by Dosage Forms (2027-2032) & (USD Million)
Table 73. World InavolisibTablets Average Price by Dosage Forms (2021-2026) & (US$/Unit)
Table 74. World InavolisibTablets Average Price by Dosage Forms (2027-2032) & (US$/Unit)
Table 75. World InavolisibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World InavolisibTablets Production by Application (2021-2026) & (Units)
Table 77. World InavolisibTablets Production by Application (2027-2032) & (Units)
Table 78. World InavolisibTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World InavolisibTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World InavolisibTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World InavolisibTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche InavolisibTablets Product and Services
Table 85. Roche InavolisibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Genentech Basic Information, Manufacturing Base and Competitors
Table 89. Genentech Major Business
Table 90. Genentech InavolisibTablets Product and Services
Table 91. Genentech InavolisibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Genentech Recent Developments/Updates
Table 93. Genentech Competitive Strengths & Weaknesses
Table 94. Global Key Players of InavolisibTablets Upstream (Raw Materials)
Table 95. Global InavolisibTablets Typical Customers
Table 96. InavolisibTablets Typical Distributors
LIST OF FIGURES
Figure 1. InavolisibTablets Picture
Figure 2. World InavolisibTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World InavolisibTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World InavolisibTablets Production (2021-2032) & (Units)
Figure 5. World InavolisibTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World InavolisibTablets Production Value Market Share by Region (2021-2032)
Figure 7. World InavolisibTablets Production Market Share by Region (2021-2032)
Figure 8. North America InavolisibTablets Production (2021-2032) & (Units)
Figure 9. Europe InavolisibTablets Production (2021-2032) & (Units)
Figure 10. China InavolisibTablets Production (2021-2032) & (Units)
Figure 11. Japan InavolisibTablets Production (2021-2032) & (Units)
Figure 12. India InavolisibTablets Production (2021-2032) & (Units)
Figure 13. InavolisibTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World InavolisibTablets Consumption (2021-2032) & (Units)
Figure 16. World InavolisibTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States InavolisibTablets Consumption (2021-2032) & (Units)
Figure 18. China InavolisibTablets Consumption (2021-2032) & (Units)
Figure 19. Europe InavolisibTablets Consumption (2021-2032) & (Units)
Figure 20. Japan InavolisibTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea InavolisibTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN InavolisibTablets Consumption (2021-2032) & (Units)
Figure 23. India InavolisibTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of InavolisibTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for InavolisibTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for InavolisibTablets Markets in 2025
Figure 27. United States VS China: InavolisibTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: InavolisibTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: InavolisibTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 31. China Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 33. World InavolisibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World InavolisibTablets Production Value Market Share by Type in 2025
Figure 35. 5 mg
Figure 36. 10 mg
Figure 37. World InavolisibTablets Production Market Share by Type (2021-2032)
Figure 38. World InavolisibTablets Production Value Market Share by Type (2021-2032)
Figure 39. World InavolisibTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World InavolisibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 41. World InavolisibTablets Production Value Market Share by Sales Channel in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World InavolisibTablets Production Market Share by Sales Channel (2021-2032)
Figure 46. World InavolisibTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 47. World InavolisibTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 48. World InavolisibTablets Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 49. World InavolisibTablets Production Value Market Share by Route of Administration in 2025
Figure 50. Oral Administration
Figure 51. Intravenous Administration, IV
Figure 52. World InavolisibTablets Production Market Share by Route of Administration (2021-2032)
Figure 53. World InavolisibTablets Production Value Market Share by Route of Administration (2021-2032)
Figure 54. World InavolisibTablets Average Price by Route of Administration (2021-2032) & (US$/Unit)
Figure 55. World InavolisibTablets Production Value by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 56. World InavolisibTablets Production Value Market Share by Dosage Forms in 2025
Figure 57.Tablet
Figure 58. Capsule
Figure 59. World InavolisibTablets Production Market Share by Dosage Forms (2021-2032)
Figure 60. World InavolisibTablets Production Value Market Share by Dosage Forms (2021-2032)
Figure 61. World InavolisibTablets Average Price by Dosage Forms (2021-2032) & (US$/Unit)
Figure 62. World InavolisibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World InavolisibTablets Production Value Market Share by Application in 2025
Figure 64. HR+/HER2- Advanced or Metastatic Breast Cancer
Figure 65. PIK3CA-Mutated Tumor Targeted Therapy
Figure 66. Combination Therapy Applications
Figure 67. Others
Figure 68. World InavolisibTablets Production Market Share by Application (2021-2032)
Figure 69. World InavolisibTablets Production Value Market Share by Application (2021-2032)
Figure 70. World InavolisibTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. InavolisibTablets Industry Chain
Figure 72. InavolisibTablets Procurement Model
Figure 73. InavolisibTablets Sales Model
Figure 74. InavolisibTablets Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. InavolisibTablets Picture
Figure 2. World InavolisibTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World InavolisibTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World InavolisibTablets Production (2021-2032) & (Units)
Figure 5. World InavolisibTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World InavolisibTablets Production Value Market Share by Region (2021-2032)
Figure 7. World InavolisibTablets Production Market Share by Region (2021-2032)
Figure 8. North America InavolisibTablets Production (2021-2032) & (Units)
Figure 9. Europe InavolisibTablets Production (2021-2032) & (Units)
Figure 10. China InavolisibTablets Production (2021-2032) & (Units)
Figure 11. Japan InavolisibTablets Production (2021-2032) & (Units)
Figure 12. India InavolisibTablets Production (2021-2032) & (Units)
Figure 13. InavolisibTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World InavolisibTablets Consumption (2021-2032) & (Units)
Figure 16. World InavolisibTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States InavolisibTablets Consumption (2021-2032) & (Units)
Figure 18. China InavolisibTablets Consumption (2021-2032) & (Units)
Figure 19. Europe InavolisibTablets Consumption (2021-2032) & (Units)
Figure 20. Japan InavolisibTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea InavolisibTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN InavolisibTablets Consumption (2021-2032) & (Units)
Figure 23. India InavolisibTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of InavolisibTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for InavolisibTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for InavolisibTablets Markets in 2025
Figure 27. United States VS China: InavolisibTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: InavolisibTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: InavolisibTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 31. China Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers InavolisibTablets Production Market Share 2025
Figure 33. World InavolisibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World InavolisibTablets Production Value Market Share by Type in 2025
Figure 35. 5 mg
Figure 36. 10 mg
Figure 37. World InavolisibTablets Production Market Share by Type (2021-2032)
Figure 38. World InavolisibTablets Production Value Market Share by Type (2021-2032)
Figure 39. World InavolisibTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World InavolisibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 41. World InavolisibTablets Production Value Market Share by Sales Channel in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World InavolisibTablets Production Market Share by Sales Channel (2021-2032)
Figure 46. World InavolisibTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 47. World InavolisibTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 48. World InavolisibTablets Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 49. World InavolisibTablets Production Value Market Share by Route of Administration in 2025
Figure 50. Oral Administration
Figure 51. Intravenous Administration, IV
Figure 52. World InavolisibTablets Production Market Share by Route of Administration (2021-2032)
Figure 53. World InavolisibTablets Production Value Market Share by Route of Administration (2021-2032)
Figure 54. World InavolisibTablets Average Price by Route of Administration (2021-2032) & (US$/Unit)
Figure 55. World InavolisibTablets Production Value by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 56. World InavolisibTablets Production Value Market Share by Dosage Forms in 2025
Figure 57.Tablet
Figure 58. Capsule
Figure 59. World InavolisibTablets Production Market Share by Dosage Forms (2021-2032)
Figure 60. World InavolisibTablets Production Value Market Share by Dosage Forms (2021-2032)
Figure 61. World InavolisibTablets Average Price by Dosage Forms (2021-2032) & (US$/Unit)
Figure 62. World InavolisibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World InavolisibTablets Production Value Market Share by Application in 2025
Figure 64. HR+/HER2- Advanced or Metastatic Breast Cancer
Figure 65. PIK3CA-Mutated Tumor Targeted Therapy
Figure 66. Combination Therapy Applications
Figure 67. Others
Figure 68. World InavolisibTablets Production Market Share by Application (2021-2032)
Figure 69. World InavolisibTablets Production Value Market Share by Application (2021-2032)
Figure 70. World InavolisibTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. InavolisibTablets Industry Chain
Figure 72. InavolisibTablets Procurement Model
Figure 73. InavolisibTablets Sales Model
Figure 74. InavolisibTablets Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
